Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation

被引:0
作者
Yang, Boyu [1 ]
Wu, Shaowen [1 ]
Yu, Shanshan [1 ]
Liang, Xiaoling [1 ]
Liu, Qifa [2 ]
Huang, Fen [2 ]
Liang, Lingyi [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangdong Prov Clin Res Ctr Ocular Dis,State Key, Guangdong Prov Key Lab Ophthalmol & Visual Sci, Guangzhou, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
BONE-MARROW-TRANSPLANTATION; VISUAL-EVOKED POTENTIALS; VERSUS-HOST-DISEASE; CYTOMEGALOVIRUS RETINITIS; OCULAR FINDINGS; SOLID-ORGAN; EYE;
D O I
10.1038/s41433-022-02250-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To study the posterior segment complications (PSC) and the risk factors in patients after allogeneic hematopoietic stem cell transplantation (HSCT). Methods This cross-sectional, case-control study enroled 143 patients who received allogeneic HSCT. Comprehensive ocular examinations were performed to evaluate PSC and ocular Graft-versus-Host Disease (oGVHD). PSC was diagnosed based on the characteristic fundus findings and auxiliary examinations. Visual-evoked potential was examined in patients with unexplained visual loss and suspected visual pathway pathology (VPP). Ocular surface disease index, corneal fluorescein staining, conjunctival injection and Schirmer's test were scored to diagnose oGVHD. Results PSC was detected in 36 (25.2%) patients, while 107 (74.8%) patients were not. Among them, 102 (71.3%) patients were diagnosed with oGVHD. The most common PSC included cytomegalovirus retinitis (13/143, 9.1%) and VPP (7/143, 4.9%). Central nervous system relapse of leukaemia was detected in four out of seven cases of VPP. Patients with PSC had worse visual acuity, lower prevalence and milder severity of oGVHD, and more donors from unrelated and human leucocyte antigen (HLA)-mismatch (all P < 0.05). PSC was associated with transplant from unrelated (OR = 6.494, 95% CI: 1.635-25.794, P = 0.008) and HLA-mismatched (OR = 7.193, 95% CI: 2.829-18.291, P < 0.001) donor but not with the occurrence of systemic GVHD or oGVHD. Conclusions PSC in post-HSCT patients was more common than previously noted, deserving the concern of ophthalmologists, especially in patients with unrelated or HLA-mismatched donors.
引用
收藏
页码:1816 / 1821
页数:6
相关论文
共 50 条
  • [31] Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome
    Zhang, Xiao-hui
    Liu, Xiao
    Wang, Qian-ming
    He, Yun
    Zhu, Xiao-lu
    Zhang, Jia-min
    Han, Wei
    Chen, Huan
    Chen, Yu-hong
    Wang, Feng-rong
    Wang, Jing-zhi
    Zhang, Yuan-yuan
    Mo, Xiao-dong
    Chen, Yao
    Wang, Yu
    Fu, Hai-xia
    Chang, Ying-jun
    Xu, Lan-ping
    Liu, Kai-Yan
    Huang, Xiao-Jun
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (02) : 171 - 181
  • [32] Potential factors for and the prognostic impact of ascites after allogeneic hematopoietic stem cell transplantation
    Kubo, Hiroyuki
    Imataki, Osamu
    Fukumoto, Tetsuya
    Kawanaka, Yui
    Ishida, Tomoya
    Kubo, Yukiko Hamasaki
    Kida, Jun-ichiro
    Uemura, Makiko
    Fujita, Haruyuki
    Kadowaki, Norimitsu
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [33] Ocular Complications in Children Within 1 Year After Hematopoietic Stem Cell Transplantation
    Ayuso, Viera Kalinina
    Hettinga, Ymkje
    van der Does, Patricia
    Boelens, Jaap J.
    Rothova, Aniki
    de Boer, Joke
    JAMA OPHTHALMOLOGY, 2013, 131 (04) : 470 - 475
  • [34] Cataract after allogeneic hematopoietic stem cell transplantation inchildhood
    Fahnehjelm, Kristina Tear
    Tornquist, Alba Lucia
    Olsson, Monica
    Backstrom, Ingrid
    Gronlund, Marita Andersson
    Winiarski, Jacek
    ACTA PAEDIATRICA, 2016, 105 (01) : 82 - 89
  • [35] Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Williams, Kirsten M.
    Chien, Jason W.
    Gladwin, Mark T.
    Pavletic, Steven Z.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (03): : 306 - 314
  • [36] Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
    Lu, Yingxue
    Ma, Xiaojing
    Pan, Jie
    Ma, Rongqiang
    Jiang, Yujie
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
  • [37] Heart failure after allogeneic hematopoietic stem cell transplantation
    Mo, Xiao-Dong
    Xu, Lan-Ping
    Liu, Dai-Hong
    Zhang, Xiao-Hui
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Yu
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Zhao, Ting
    Yan, Chen-Hua
    Sun, Yu-Qian
    Liu, Kai-Yan
    Huang, Xiao-Jun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (06) : 2502 - 2506
  • [38] Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation
    Bondeelle, Louise
    Bergeron, Anne
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (01) : 105 - 119
  • [39] Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation
    Bhatt, Vijaya Raj
    Balasetti, Vamshi
    Jasem, Jagar A.
    Giri, Smith
    Armitage, James O.
    Loberiza, Fausto R., Jr.
    Bociek, R. Gregory
    Bierman, Philip J.
    Maness, Lori J.
    Vose, Julie M.
    Fayad, Pierre
    Akhtari, Mojtaba
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (10) : 606 - 611
  • [40] Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update
    Mohty, B.
    Mohty, M.
    BLOOD CANCER JOURNAL, 2011, 1 : e16 - e16